3 completed. 1 Not applicable, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow TTR Cardiac Amyloidosis: new trials by email Literature Review of TTR Cardiac Amyloidosis trials Research Report on TTR Cardiac Amyloidosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| N-of-1 for Beta-Blockers in Cardiac Amyloidosis Beta blocker - Cardiac Amyloidosis, Heart Diseases | Phase 4 | Completed | Weill Medical College of Cornell University | 14 | 2024-01-31 | 2026-07-29 |
| Long-term Monitoring of Patients With Cardiac Amyloidosis With Implantable Event Monitors Biotronik Biomonitor 3 implant of device, Biotronik Biomonitor 3 explant of device - TTR Cardiac Amyloidosis | Not applicable | Completed | Mayo Clinic | 24 | 2020-10-07 | 2024-04-16 |
| A Study of Doxycycline and Tauroursodeoxycholic Acid (Doxy/TUDCA) Plus Standard Supportive Therapy Versus Standard Supportive Therapy Alone in Cardiac Amyloidosis Caused by Transthyretin Doxycycline and tauroursodeoxycholic acid, Standard of care - TTR Cardiac Amyloidosis | Phase 3 | Completed | Fondazione IRCCS Policlinico San Matteo di Pavia | 102 | 2018-04-11 | 2024-07-11 |
Amyloid Neuropathies, Familial (1) · Heart Diseases (1) · Heart Failure (1)
Amyloid Neuropathies (1) · Amyloidosis (1) · Amyloidosis, Familial (1) · Cardiovascular Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Heredodegenerative Disorders, Nervous System (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1) · Nervous System Diseases (1) · Neurodegenerative Diseases (1) · Neuromuscular Diseases (1) · Nutritional and Metabolic Diseases (1) · Peripheral Nervous System Diseases (1) · Proteostasis Deficiencies (1)
Adrenergic beta-Antagonists (1) · Doxycycline (1) · Standard of Care (1) · ursodoxicoltaurine (1)
Fondazione IRCCS Policlinico San Matteo di Pavia (1) · Mayo Clinic (1) · Weill Medical College of Cornell University (1)
United States (2) · Italy (1)
Omar Abou Ezzeddine, MD, MS (1) · Parag Goyal, MD, MSc (1)
R24AG064025 (1)